DUGGAN ROBERT W bought SMMT
October 21, 2025 · Form 4 insider transaction
DUGGAN ROBERT W bought 13,980,789 shares of Summit Therapeutics Inc. at $18.74 per share, a transaction worth $262.00M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,980,789
Price
$18.74
Total value
$262.00M
InsiderDUGGAN ROBERT W
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 21, 2025
Filing dateOctober 23, 2025
Shares owned after570,073,879
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025.